Hoey Investments »

Allogene Therapeutics shares owned by Hoey Investments

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Hoey Investments from 13F filings

Historical chart of Hoey Investments investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Hoey Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Hoey Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3k 300 4.47

More positions owned by Hoey Investments

Nvidia Corporation Call Call Option (Principal) (NVDA)
Amazon Call Call Option (Principal) (AMZN)
Microsoft Corporation (MSFT)
Meta Platforms Call Call Option (Principal) (META)
Apple (AAPL)
Palo Alto Networks Call Call Option (Principal) (PANW)
Wells Fargo & Company (WFC)
Advanced Micro Devices (AMD)
Bank of America Corporation (BAC)
Uber Technologies (UBER)
General Electric Com New (GE)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Arm Holdings Call Call Option (Principal) (ARM)
Lowe's Companies (LOW)

View all positions for Hoey Investments

Top funds holding Allogene Therapeutics

FMR
Tpg Gp A
BlackRock
Vanguard Group
PRIMECAP Management Company
Jpmorgan Chase & Co
T. Rowe Price Associates
Boxer Capital
Citadel Advisors
Frazier Life Sciences Management
Woodline Partners
Geode Capital Management
Morgan Stanley
Dimensional Fund Advisors
Two Sigma Investments

View all funds holding Allogene Therapeutics